These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10369133)

  • 21. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NKG2D Enhances Double-Negative T Cell Regulation of B Cells.
    Hu SH; Zhang LH; Gao J; Guo JH; Xun XD; Xiang X; Cheng Q; Li Z; Zhu JY
    Front Immunol; 2021; 12():650788. PubMed ID: 34220808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naive CD8(+) but not CD4(+) T cells induce maturation of dendritic cells.
    Schüler T; Blankenstein T
    J Mol Med (Berl); 2002 Aug; 80(8):533-41. PubMed ID: 12185454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
    Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
    Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
    Kelleher M; Beverley PC
    J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.
    Hermans IF; Ritchie DS; Yang J; Roberts JM; Ronchese F
    J Immunol; 2000 Mar; 164(6):3095-101. PubMed ID: 10706699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells.
    Ding CL; Yao K; Zhang TT; Zhou F; Xu L; Xu JY
    World J Gastroenterol; 2003 Jul; 9(7):1512-5. PubMed ID: 12854153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development, maturation, and turnover rate of mouse spleen dendritic cell populations.
    Kamath AT; Pooley J; O'Keeffe MA; Vremec D; Zhan Y; Lew AM; D'Amico A; Wu L; Tough DF; Shortman K
    J Immunol; 2000 Dec; 165(12):6762-70. PubMed ID: 11120796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge.
    Hermans IF; Daish A; Moroni-Rawson P; Ronchese F
    Cancer Immunol Immunother; 1997 Aug; 44(6):341-7. PubMed ID: 9298937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of CD4 T cells and the source of major histocompatibility complex class II-restricted peptides on cytotoxic T-cell priming by dendritic cells.
    Faiola B; Doyle C; Gilboa E; Nair S
    Immunology; 2002 Jan; 105(1):47-55. PubMed ID: 11849314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
    Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
    J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hookworm tissue inhibitor of metalloproteases (Ac-TMP-1) modifies dendritic cell function and induces generation of CD4 and CD8 suppressor T cells.
    Cuéllar C; Wu W; Mendez S
    PLoS Negl Trop Dis; 2009 May; 3(5):e439. PubMed ID: 19468296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Frequencies of Anti-Host Reactive CD8+ T Cells Ignore Non-Hematopoietic Antigen after Bone Marrow Transplantation in a Murine Model.
    Gassa A; Kalkavan H; Jian F; Duhan V; Khairnar V; Shaabani N; Honke N; Carpinteiro A; Botezatu L; Crivello P; Dolff S; Ferencik S; Häussinger D; Khandanpour C; Fleischhauer K; Witzke O; Wahlers T; Hardt C; Lang PA; Lang KS
    Cell Physiol Biochem; 2016; 38(4):1343-53. PubMed ID: 27007114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced tumor responses to dendritic cells in the absence of CD8-positive cells.
    Ribas A; Wargo JA; Comin-Anduix B; Sanetti S; Schumacher LY; McLean C; Dissette VB; Glaspy JA; McBride WH; Butterfield LH; Economou JS
    J Immunol; 2004 Apr; 172(8):4762-9. PubMed ID: 15067052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4 and CD8 expressions in African green monkey helper T lymphocytes: implication for resistance to SIV infection.
    Murayama Y; Amano A; Mukai R; Shibata H; Matsunaga S; Takahashi H; Yoshikawa Y; Hayami M; Noguchi A
    Int Immunol; 1997 Jun; 9(6):843-51. PubMed ID: 9199967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.
    Malowany JI; McCormick S; Santosuosso M; Zhang X; Aoki N; Ngai P; Wang J; Leitch J; Bramson J; Wan Y; Xing Z
    Mol Ther; 2006 Apr; 13(4):766-75. PubMed ID: 16343993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants.
    Chua MM; MacNamara KC; San Mateo L; Shen H; Weiss SR
    J Virol; 2004 Feb; 78(3):1150-9. PubMed ID: 14722270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.